XOSPATA Presentation
XOSPATA® (gilteritinib): A Targeted Therapeutic Approach for Relapsed or Refractory FLT3m+ AML Patients (077-0621-PM)
PRESENTER
Catherine Lai, M.D., M.P.H.
Medstar Georgetown University Hospital; Lombardi Comprehensive Cancer Center; Georgetown University Medical Center
Washington, DC
RSVP by July 15 To:
https://astellas.virtualspeakercast.net/Registration/index/275
Phone: 973-930-3192
Email: melba.vasquez@astellas.com
Register at https://astellas.virtualspeakercast.net/Registration/index/275
A confirmation will then be sent to you with the program web link and call-in number